Ocugen Intangible Assets from 2010 to 2026
| OCGN Stock | USD 1.96 0.10 5.38% |
Intangible Assets | First Reported 2010-12-31 | Previous Quarter 180 K | Current Value 171 K | Quarterly Volatility 189.1 K |
Check Ocugen financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ocugen's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.9 M, Interest Expense of 4.2 M or Selling General Administrative of 15.4 M, as well as many indicators such as Price To Sales Ratio of 87.23, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Ocugen financial statements analysis is a perfect complement when working with Ocugen Valuation or Volatility modules.
Ocugen | Intangible Assets | Build AI portfolio with Ocugen Stock |
Evaluating Ocugen's Intangible Assets across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Ocugen Inc's fundamental strength.
Latest Ocugen's Intangible Assets Growth Pattern
Below is the plot of the Intangible Assets of Ocugen Inc over the last few years. It is non-physical assets possessed by a company, such as patents, trademarks, and copyrights, which provide long-term value. Ocugen's Intangible Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ocugen's overall financial position and show how it may be relating to other accounts over time.
| Intangible Assets | 10 Years Trend |
|
Intangible Assets |
| Timeline |
Ocugen Intangible Assets Regression Statistics
| Arithmetic Mean | 313,000 | |
| Geometric Mean | 270,984 | |
| Coefficient Of Variation | 60.40 | |
| Mean Deviation | 165,294 | |
| Median | 200,000 | |
| Standard Deviation | 189,055 | |
| Sample Variance | 35.7B | |
| Range | 459K | |
| R-Value | (0.82) | |
| Mean Square Error | 12.6B | |
| R-Squared | 0.67 | |
| Significance | 0.000061 | |
| Slope | (30,618) | |
| Total Sum of Squares | 571.9B |
Ocugen Intangible Assets History
About Ocugen Financial Statements
Ocugen investors utilize fundamental indicators, such as Intangible Assets, to predict how Ocugen Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Intangible Assets | 180 K | 171 K |
Pair Trading with Ocugen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ocugen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocugen will appreciate offsetting losses from the drop in the long position's value.Moving together with Ocugen Stock
Moving against Ocugen Stock
| 0.52 | OSE | OSE Pharma SA | PairCorr |
| 0.44 | VCYT | Veracyte | PairCorr |
| 0.4 | OB3 | OPTIBIOTIX HLTH PLC | PairCorr |
| 0.37 | DMAC | DiaMedica Therapeutics | PairCorr |
| 0.37 | VANI | Vivani Medical | PairCorr |
The ability to find closely correlated positions to Ocugen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ocugen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ocugen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ocugen Inc to buy it.
The correlation of Ocugen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ocugen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ocugen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ocugen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Ocugen Correlation against competitors. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Biotechnology sector continue expanding? Could Ocugen diversify its offerings? Factors like these will boost the valuation of Ocugen. Anticipated expansion of Ocugen directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Ocugen data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.22) | Revenue Per Share | Quarterly Revenue Growth 0.542 | Return On Assets | Return On Equity |
Investors evaluate Ocugen Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Ocugen's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Ocugen's market price to deviate significantly from intrinsic value.
It's important to distinguish between Ocugen's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Ocugen should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Ocugen's market price signifies the transaction level at which participants voluntarily complete trades.